U.S. Approves Gilead’s New Hepatitis C Drug that Costs $1,050 per day

October 10, 2014 9:48 PM

6 0

U.S. Approves Gilead’s New Hepatitis C Drug that Costs $1,050 per day

A new hepatitis treatment drug developed by Gilead Sciences was given a regulatory approval on Friday, but it is more expensive than its predecessor, Sovaldi.

A new hepatitis treatment drug developed by Gilead Sciences was given a regulatory approval on Friday, but it is more expensive than its predecessor, Sovaldi.

Read more

To category page

Loading...